24/07/2007
Cancer test kit 'could lead to 20,000 fewer deaths'
Deaths from bowel cancer could be dramatically reduced if people use a self-testing kit being sent to people in their sixties throughout the country, a cancer charity has predicted.
Cancer Research UK said that there would be up to 20,000 fewer deaths from the disease in the next 20 years if just 60% of those eligible for bowel screening used the Faecal Occult Blood Test (FOBT). The figure rose to 25,000 if 80% of people used the test.
The bowel screening programme's self test kit, which is part of Cancer Research UK's Screening Matters campaign, is designed to allow people to take faecal samples in the privacy of their own home and send them for testing.
If blood is found during the test, the person would then be invited for a colonoscopy. The test should be repeated every two years.
David Phillips, 67, a retired swimming coach from Coventry, was part of the pilot bowel screening programme and was sent a test kit in 2001. His wife persuaded him to do the test and the result showed blood in the sample. The test was repeated and Mr Phillips was asked to have a colonoscopy. Bowel cancer was diagnosed and he had surgery two weeks later. He is now fully recovered and has six-monthly check-ups.
Mr Phillips said: "I think I was very lucky that the screening test picked up on something that could have developed into a much worse situation. Early diagnosis was the reason I made such a good recovery.
"The bowel screening programme is certainly the way forward as it could help so many people as it helped me. Without screening I probably would not have known that I had cancer, but thanks to screening I am here to tell the story."
Maxine Taylor, Cancer Research UK's executive director of policy and communications, said: "These new predictions indicate how valuable the NHS bowel screening programme will be in cutting the rising toll of bowel cancer deaths. It is important that the programme is rolled out as efficiently and quickly as possible so that the maximum number of eligible men and women can benefit."
Cancer Research UK has also called on the government to screen at least three million more people over the next five years; reduce the variation in screening across the UK; reach out to people eligible for screening who aren't taking part; provide the best possible screening programmes through funding, staffing and measuring success.
The campaign will also ask supporters to sign a pledge card, available from Cancer Research UK shops, showing their support for the political aims and to make a personal pledge that they will attend screening when invited.
There are around 35,000 cases of bowel cancer diagnosed each year in the UK, with more than 16,000 people dying from the disease. Bowel cancer is also the second most common cause of cancer death in the UK.
(KMcA/SP)
Cancer Research UK said that there would be up to 20,000 fewer deaths from the disease in the next 20 years if just 60% of those eligible for bowel screening used the Faecal Occult Blood Test (FOBT). The figure rose to 25,000 if 80% of people used the test.
The bowel screening programme's self test kit, which is part of Cancer Research UK's Screening Matters campaign, is designed to allow people to take faecal samples in the privacy of their own home and send them for testing.
If blood is found during the test, the person would then be invited for a colonoscopy. The test should be repeated every two years.
David Phillips, 67, a retired swimming coach from Coventry, was part of the pilot bowel screening programme and was sent a test kit in 2001. His wife persuaded him to do the test and the result showed blood in the sample. The test was repeated and Mr Phillips was asked to have a colonoscopy. Bowel cancer was diagnosed and he had surgery two weeks later. He is now fully recovered and has six-monthly check-ups.
Mr Phillips said: "I think I was very lucky that the screening test picked up on something that could have developed into a much worse situation. Early diagnosis was the reason I made such a good recovery.
"The bowel screening programme is certainly the way forward as it could help so many people as it helped me. Without screening I probably would not have known that I had cancer, but thanks to screening I am here to tell the story."
Maxine Taylor, Cancer Research UK's executive director of policy and communications, said: "These new predictions indicate how valuable the NHS bowel screening programme will be in cutting the rising toll of bowel cancer deaths. It is important that the programme is rolled out as efficiently and quickly as possible so that the maximum number of eligible men and women can benefit."
Cancer Research UK has also called on the government to screen at least three million more people over the next five years; reduce the variation in screening across the UK; reach out to people eligible for screening who aren't taking part; provide the best possible screening programmes through funding, staffing and measuring success.
The campaign will also ask supporters to sign a pledge card, available from Cancer Research UK shops, showing their support for the political aims and to make a personal pledge that they will attend screening when invited.
There are around 35,000 cases of bowel cancer diagnosed each year in the UK, with more than 16,000 people dying from the disease. Bowel cancer is also the second most common cause of cancer death in the UK.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
30 October 2012
Breast Cancer Screening Leads To 'Over Diagnoses'
Women are to be nformed over breast cancer screening issues in the UK after a review highlights the potential harms of being tested. The review panel, led by Prof Michael Marmot, from University College London, found screening had "contributed to reducing deaths" but also "resulted in some overdiagnosis".
Breast Cancer Screening Leads To 'Over Diagnoses'
Women are to be nformed over breast cancer screening issues in the UK after a review highlights the potential harms of being tested. The review panel, led by Prof Michael Marmot, from University College London, found screening had "contributed to reducing deaths" but also "resulted in some overdiagnosis".
02 July 2003
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
Charity outlines guidelines for cervical screenings
All women aged between 25 and 49 should be offered cervical screening every three years – but five years is regular enough for women aged 50 to 64 – according to a new report by Cancer Research UK.
25 September 2009
Screening For Prostate Cancer 'Remains Controversial'
There is not enough evidence to support routine prostate cancer screening. Two papers published on bmj.com today conclude that there is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test.
Screening For Prostate Cancer 'Remains Controversial'
There is not enough evidence to support routine prostate cancer screening. Two papers published on bmj.com today conclude that there is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test.
12 September 2011
Bowel Cancer Death Rates Must Not Be Ignored Warns Charity
Figures issued today by Beating Bowel Cancer reveal that bowel cancer death rates vary significantly across the UK, depending on where you live. These latest statistics released by the charity show that there is a three-fold variation in bowel cancer death rates between the best and worst performing areas across the UK.
Bowel Cancer Death Rates Must Not Be Ignored Warns Charity
Figures issued today by Beating Bowel Cancer reveal that bowel cancer death rates vary significantly across the UK, depending on where you live. These latest statistics released by the charity show that there is a three-fold variation in bowel cancer death rates between the best and worst performing areas across the UK.
28 April 2010
Sexual Infection Testing Beats Normal Cancer Smear Detection Rates
A new study has revealed that a screening test for sexually transmitted infection detects more cervical severe pre-cancerous cells than conventional cancer screening tests. The relatively new test is known as the HPV test (Human papillomavirus) and is an established cervical screening programme.
Sexual Infection Testing Beats Normal Cancer Smear Detection Rates
A new study has revealed that a screening test for sexually transmitted infection detects more cervical severe pre-cancerous cells than conventional cancer screening tests. The relatively new test is known as the HPV test (Human papillomavirus) and is an established cervical screening programme.